Delivery Order SPE2DE21D7020-SPE2D626F1989
- Not listed
- Boston Scientific Corp has been awarded a delivery order valued at $11,936.05 by the Defense Health Agency's Medical Supply Chain for the supply of 38mm NG synthetic material, with performance in Marlborough, MA and completion expected by September 29, 2025. The contract utilizes a fixed-price pricing model with economic price adjustment provisions and was awarded without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. This delivery order...
- Boston Scientific Corp has been awarded a delivery order valued at $6,437.48 for medical supply provision under the Defense Health Agency's Medical Supply Chain program. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, carries an ultimate completion date of June 16, 2025, and was executed on June 9, 2025. The order involves the supply of NG synthetic material in 38mm configuration and will be performed at Boston Scientific's facility in...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,118.95 by the Defense Health Agency's Medical Supply Chain on September 16, 2025. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of September 23, 2025 and carries no set-aside designation, indicating open competition in the federal marketplace. The work will be performed at Boston Scientific's...
- Boston Scientific Corp, a major global medical technology provider headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $36,734.61 by the Defense Health Agency's Medical Supply Chain on August 15, 2025, with an ultimate completion date of August 22, 2025. The contract, which utilizes economic price adjustment provisions, is classified as contract number 4569107318 and represents a 4mm synthetic material delivery to support the agency's medical supply...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $7,669.40 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, designated as 4568924698 for NG synthetic MR US 38MM medical supplies, represents a non-competitive award with no set-aside designation. Boston Scientific will perform this work at its...
- Boston Scientific Corp, a global leader in medical technology headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $8,202.90 by the Defense Health Agency's Medical Supply Chain on June 24, 2025. The contract, designated as "NG SYN MR US 8MM," is not set aside for any specific business type and carries an ultimate completion date of July 1, 2025. Performance will be conducted at Boston Scientific's Marlborough, Massachusetts facility. This...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $14,776.70 by the Defense Health Agency's Medical Supply Chain on April 28, 2025. This fixed-price contract with economic price adjustment provisions covers the supply of 20mm synthetic material components and is scheduled for completion by May 5, 2025. The award carries no set-aside designation, indicating open competition in the federal marketplace....
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a $56,437.40 fixed-price delivery order by the Defense Health Agency's Medical Supply Chain on September 22, 2025. The contract, designated as a delivery order rather than a full solicitation, calls for delivery of NG SYN MR US 38MM medical supplies with an ultimate completion date of September 29, 2025. This award was made without a set-aside designation, allowing Boston...
- Boston Scientific Corp has been awarded a delivery order valued at $7,900.80 by the Defense Health Agency's Medical Supply Chain for the supply of 24mm NG synthetic material. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of August 11, 2025, following the award date of August 4, 2025. Performance will be executed at the company's facility in Marlborough, Massachusetts. This award was not designated as a...
- Boston Scientific Corp, a global medical technology company based in Marlborough, Massachusetts, has been awarded a $237,249.79 fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain on August 25, 2025. This delivery order, with an ultimate completion date of September 2, 2025, represents a component of Boston Scientific's broader federal contracting relationship with the Department of Defense healthcare system. The award carries no...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F1989Delivery Order
Boston Scientific Corp has been awarded a $6,327.08 fixed price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain for the supply of 38mm NG synthetic material. The contract, issued on October 15, 2025, with an ultimate completion date of October 22, 2025, represents a non-set-aside competitive award to the Marlborough, Massachusetts-based medical device manufacturer. Work will be performed at the company's headquarters location in Marlborough. This delivery order leverages Boston Scientific's established position as a prime contractor within the federal healthcare procurement landscape. The company's extensive portfolio of federal contracts demonstrates its capability to supply specialized medical devices and equipment to defense and civilian healthcare agencies. The award is consistent with Boston Scientific's historical performance under the Defense Health Agency's Medical Supply Chain vehicles, through which the company has delivered critical medical technologies including cardiovascular intervention tools, diagnostic systems, and specialized surgical implants to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 10/15/25 |